Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat as defensive gains offset auto slide

Mon, 18th Nov 2019 17:51

* Spanish bourse BME hits 4-year high

* Volkswagen cuts sales and profit forecast

* Defensive shares gain amid trade uncertainty

* FTSE 100 outperforms
(Updates to close, changes quotes, adds news items)

By Medha Singh and Agamoni Ghosh

Nov 18 (Reuters) - European stocks ended flat on Monday as a
spurt of defensive buying over uncertainty surrounding
U.S.-China trade talks helped temper losses in the auto sector.

The pan-European STOXX 600 index finished little
changed, after having spent most of the session in negative
territory.

The European automobiles and parts sector dropped
2.1%, its steepest fall in about four weeks, with Germany's
Volkswagen leading declines after it slashed its
operating profit and sales growth outlook due to slowdown in the
auto sector.

"Volkswagen is seen as a barometer for the industry and any
kind of warning from them can be concerning," said David Madden,
market analyst at CMC Markets in London.

This comes after a string of automakers including fellow
German peer Daimler and part supplier Continental
warned of tough times for an industry facing higher
investments into cleaner and self-driving technologies.

Also weighing on the sector was an over 3% decline in shares
of France's Peugeot after Deutsche Bank downgraded the
stock to "hold."

Conflicting trade headlines kept investors cautious with
sectors traditionally considered defensive, such as real estate
, utilities and healthcare leading
gains.

News on the trade war was conflicting. Sentiment in the
afternoon took a hit after a CNBC report said the mood in
Beijing about a deal was pessimistic due to U.S. President
Donald Trump's reluctance to roll back tariffs.

However, late in the session, the Trump administration
issued a new 90-day extension allowing U.S. companies to
continue doing business with China's Huawei Technologies Co Ltd
.

"The comments from both countries are getting hard to follow
now, they change their tone every other day," said Hubert de
Barochez, economist at Capital Economics, London.

Gains in defensive stocks including AstraZeneca,
GlaxoSmithKline and British American Tobacco
helped London's blue-chip FTSE 100 rise 0.1%, to
outperform the broader market.

Optimism surrounding a Sino-U.S. trade talks and better than
expected corporate results had helped STOXX 600 hit 4 year high
last week.

In a bright spot, shares of Bolsas y Mercados Espanoles
(BME) rocketed 38% as stock market operator Euronext
and Switzerland's SIX sparked a bidding war for the
Spanish firm, with both trying to snap up one of Europe's last
standalone stock exchanges.

Qiagen jumped 8% after the German genetic testing
company said it would start talks with several potential
suitors.
(Reporting by Medha Singh and Agamoni Ghosh in Bengaluru;
Editing by Shounak Dasgupta, Patrick Graham and Toby Chopra)

More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.